Cargando…

Targeting NaPi-IIb for Hyperphosphatemia in Chronic Kidney Disease Patients - The Dead End?

Detalles Bibliográficos
Autores principales:	Apetrii, Mugurel, Covic, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938199/ https://www.ncbi.nlm.nih.gov/pubmed/33735330 http://dx.doi.org/10.1016/j.ekir.2021.01.017

Ejemplares similares

Phosphate reabsorption in the kidney: NaPi-IIb or not IIb
por: Burns, David, et al.
Publicado: (2020)

NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients
por: Maruyama, Sonomi, et al.
Publicado: (2020)

Constitutive depletion of Slc34a2/NaPi-IIb in rats causes perinatal mortality
por: Pastor-Arroyo, Eva Maria, et al.
Publicado: (2021)

Nutrition in Chronic Kidney Disease—The Role of Proteins and Specific Diets
por: Apetrii, Mugurel, et al.
Publicado: (2021)

High Phosphorus Diet-Induced Changes in NaPi-IIb Phosphate Transporter Expression in the Rat Kidney: DNA Microarray Analysis
por: Suyama, Tatsuya, et al.
Publicado: (2012)

Differential regulation of the renal sodium-phosphate cotransporters NaPi-IIa, NaPi-IIc, and PiT-2 in dietary potassium deficiency
por: Breusegem, Sophia Y., et al.
Publicado: (2009)

The Influence of Dietary Calcium and Phosphorus Imbalance on Intestinal NaPi-IIb and Calbindin mRNA Expression and Tibia Parameters of Broilers
por: Li, Jianhui, et al.
Publicado: (2012)

Structural models of the NaPi-II sodium-phosphate cotransporters
por: Fenollar-Ferrer, Cristina, et al.
Publicado: (2018)

The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction
por: Knöpfel, Thomas, et al.
Publicado: (2017)

Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder (CKD-MBD) – A systematic review and meta-analysis
por: Apetrii, Mugurel, et al.
Publicado: (2017)

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD
por: Larsson, Tobias E., et al.
Publicado: (2017)

Long-term cardio-vascular risk assessment in chronic kidney disease and kidney transplanted patients following SARS-COV-2 disease: protocol for multi-center observational match controlled trial
por: Tapoi, Laura, et al.
Publicado: (2022)

Silymarin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Voroneanu, Luminita, et al.
Publicado: (2016)

Lipid, blood pressure and kidney update 2013
por: Banach, Maciej, et al.
Publicado: (2014)

Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer
por: Nurgalieva, A.K., et al.
Publicado: (2021)

Different aspects of frailty and COVID-19: points to consider in the current pandemic and future ones
por: Hussien, Hani, et al.
Publicado: (2021)

Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence
por: Covic, Adrian, et al.
Publicado: (2013)

Hyperphosphatemia: The hidden killer in chronic kidney disease
por: Askar, Akram M.
Publicado: (2015)

Hyperphosphatemia Management in Patients with Chronic Kidney Disease
por: Shaman, Ahmed M., et al.
Publicado: (2016)

Inorganic Phosphate Modulates the Expression of the NaPi-2a Transporter in the trans-Golgi Network and the Interaction with PIST in the Proximal Tubule
por: Lanaspa, Miguel A., et al.
Publicado: (2013)

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease
por: Fouque, Denis, et al.
Publicado: (2018)

Immunohistochemical evaluation of epithelial ovarian carcinomas identifies three different expression patterns of the MX35 antigen, NaPi2b
por: Levan, Kristina, et al.
Publicado: (2017)

A brand-new cardiorenal syndrome in the COVID-19 setting
por: Apetrii, Mugurel, et al.
Publicado: (2020)

Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches
por: Anand, Ajeeta, et al.
Publicado: (2023)

Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells
por: Bulatova, Leisan, et al.
Publicado: (2022)

Trace elements in end-stage renal disease – unfamiliar territory to be revealed
por: Covic, Adrian, et al.
Publicado: (2009)

Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?
por: Wish, Jay B.
Publicado: (2023)

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
por: Shigematsu, Takashi, et al.
Publicado: (2012)

Unusual presentation of a five‐month‐old boy with NaPi2a homozygous mutation without hyperphosphaturia: Case report and review of the literature
por: Yakubov, Renata, et al.
Publicado: (2021)

Phosphate intake, hyperphosphatemia, and kidney function
por: Rubio-Aliaga, Isabel, et al.
Publicado: (2022)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200
por: Lindegren, Sture, et al.
Publicado: (2015)

Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients
por: Moon, Hongran, et al.
Publicado: (2019)

Rebmab200, a Humanized Monoclonal Antibody Targeting the Sodium Phosphate Transporter NaPi2b Displays Strong Immune Mediated Cytotoxicity against Cancer: A Novel Reagent for Targeted Antibody Therapy of Cancer
por: dos Santos, Mariana Lopes, et al.
Publicado: (2013)

Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease
por: Scaria, P. Thomas, et al.
Publicado: (2009)

Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective
por: Reddy, Yogesh NV, et al.
Publicado: (2014)

Physiological Tradeoffs of Immune Response Differs by Infection Type in Pieris napi
por: Keehnen, Naomi L. P., et al.
Publicado: (2021)

Dead or Alive?
por: Greenbaum, Carla J.
Publicado: (2012)

Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021)

Overhydration, Cardiac Function and Survival in Hemodialysis Patients
por: Onofriescu, Mihai, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vla15b9mv2nglrg169je2eiglf